Benefits
Waist Circumference Reduction
Multiple RCTs show Slimaluma significantly reduces waist circumference vs placebo. Kuriyan 2007 (n=50, 60 days) and subsequent studies. Visceral fat reduction beyond just weight loss.
Appetite Suppression
Traditional use by tribal hunters in India for hunger suppression during long hunting periods. Modern clinical evidence supports appetite control mechanism.
Body Composition Improvements
Reductions in body fat mass, body weight, BMI in clinical trials. Effects modest but consistent.
FDA Letter of No Objection
FDA issued letter of no objection for Slimaluma use in meal replacement products — regulatory acknowledgment of safety.
Comprehensive Safety Assessment
Multiple safety studies including comprehensive toxicology assessments published. Safety profile well-characterized.
Mechanism of action
Hypothalamic Appetite Center Modulation
Theoretical mechanism: pregnane glycosides modulate hypothalamic appetite control centers.
Reduced Food Intake / Caloric Deficit
Appetite suppression leads to reduced caloric intake — foundation for weight management effects.
Citrate Lyase Inhibition
Some research suggests inhibition of citrate lyase — enzyme involved in fatty acid synthesis.
Standardized Pregnane Glycoside Profile
Saanroo standardization ensures consistent active compound delivery.
Clinical trials
RCT of Slimaluma (1 g/day) vs placebo in 50 overweight Indian adults for 60 days.
50 overweight adults.
Significant reduction in waist circumference and waist:hip ratio vs placebo. Modest body weight effects.
Comprehensive toxicology studies of Slimaluma for regulatory submissions.
Animal toxicology and human safety.
Well-tolerated at supplemental doses; no significant adverse effects in long-term safety studies.
About this ingredient
SLIMALUMA is a STANDARDIZED CARALLUMA FIMBRIATA EXTRACT developed by SAANROO (formerly Gencor Pacific). CARALLUMA FIMBRIATA is a SUCCULENT in Apocynaceae family native to INDIA. TRADITIONAL USE: tribal hunters in India consumed Caralluma stems to suppress appetite during long hunting journeys.
KEY ACTIVES: PREGNANE GLYCOSIDES and MEGASTIGMANE GLYCOSIDES.
KEY DISTINCTIONS: (1) FDA LETTER OF NO OBJECTION for meal replacement products; (2) US PATENT protection; (3) MULTIPLE RCTs; (4) COMPREHENSIVE SAFETY ASSESSMENT.
EVIDENCE-BASED USES: (1) WAIST CIRCUMFERENCE REDUCTION; (2) Appetite suppression; (3) Body composition improvements; (4) Weight management adjunct; (5) MEAL REPLACEMENT applications.
CRITICAL CAUTIONS: (1) PREGNANCY/LACTATION — limited data; AVOID; (2) CHILDREN — not appropriate; (3) DIABETES MEDICATIONS — modest hypoglycemic effects; (4) DOSE — 500-1,000 mg/day; (5) APPETITE SUPPRESSION FRAMEWORK — works best with appropriate dietary structure; (6) WAIST CIRCUMFERENCE — visceral fat reduction is health-beneficial; (7) DURATION — effects build over 30-60 days; (8) WEIGHT MANAGEMENT — comprehensive approach foundational; Slimaluma especially useful for those whose challenge is appetite/portion control.